Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Zynerba Pharmaceuticals Reveals Positive Results From Phase 2 INSPIRE Trial Of Zygel In 22q11.2 Deletion Syndrome

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) revealed positive top line results from the exploratory, open label Phase 2 INSPIRE trial. Based on the positive Phase 2 data, the company will request a meeting with the U.S.

Benzinga

Chinese Analyst Provokes Country To Attack Elon Musk's Popular Starlink Satellite Service

In a paper published by the Beijing Institute of Tracking and Telecommunications Technology, a Chinese researcher urged the Chinese military to track and monitor every satellite in the Starlink network, Bloomberg reports. Tesla, Inc (NASDAQ:TSLA) chief Elon Musk’s satellite service provides internet access in over 30 countries. Ren Yuanzhen cited the pervasiveness, ability…

Benzinga

Guardforce AI Expands RaaS Business Offering In Japan, US

Guardforce AI Co Ltd (NASDAQ:GFAI) expands its Robotics-as-a-Service (RaaS) business lines with new offices in Tokyo, Japan, and San Francisco, California. The T-series robot for reception services, food delivery robots, and disinfection robots for restaurants, shopping malls, and hotels will be among the robotics solutions offered by GFAI in these two sites. "Opening…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Prospect Capital: Dividend Insights

Friday marks the last chance for investors to receive the next dividend payout from Prospect Capital (NASDAQ:PSEC).

Benzinga

Seanergy Maritime Hldgs: Dividend Insights

Friday marks the last chance for investors to receive the next dividend payout from Seanergy Maritime Hldgs (NASDAQ:SHIP).

Benzinga

Looking At Micron Technology's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bullish stance on Micron Technology. Looking at options history for Micron Technology (NASDAQ:MU) we detected 11 strange trades.

Benzinga

Krystal Biotech Files To Seek Approval For Skin Disease Candidate

Krystal Biotech, Inc. (NASDAQ: KRYS) submits biologics license application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval of B-VEC (beremagene geperpavec) in the treatment of patients with dystrophic epidermolysis bullosa (DEB).

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Short Volatility Alert: Keurig Dr Pepper Inc.

On Tuesday, shares of Keurig Dr Pepper Inc. (NASDAQ: KDP) experienced volatile short activity. After the activity, the stock price went up +1.72% to $34.94. The overall sentiment for KDP has been Bearish.

Benzinga

Short Volatility Alert: Amicus Therapeutics, Inc.

On Tuesday, shares of Amicus Therapeutics, Inc. (NASDAQ: FOLD) experienced volatile short activity. After the activity, the stock price went up +5.67% to $9.88. The overall sentiment for FOLD has been Bearish.

Benzinga

Short Volatility Alert: AstraZeneca PLC

On Tuesday, shares of AstraZeneca PLC (NASDAQ: AZN) experienced volatile short activity. After the activity, the stock price went up 2.85% to $62.83. The overall sentiment for AZN has been Bullish.

Benzinga

Analyst Ratings for PayPal Holdings

PayPal Holdings (NASDAQ:PYPL) has observed the following analyst ratings within the last quarter:

Benzinga

Expert Ratings for Beacon Roofing Supply

Within the last quarter, Beacon Roofing Supply (NASDAQ:BECN) has observed the following analyst ratings:

Benzinga

Preview: Apogee Enterprises's Earnings

Apogee Enterprises (NASDAQ:APOG) is set to give its latest quarterly earnings report on Thursday, 2022-06-23. Here's what investors need to know before the announcement. Analysts estimate that Apogee Enterprises will report an earnings per share (EPS) of $0.56.

Benzinga

A Preview Of Smith & Wesson Brands's Earnings

Smith & Wesson Brands (NASDAQ:SWBI) is set to give its latest quarterly earnings report on Thursday, 2022-06-23. Here's what investors need to know before the announcement. Analysts estimate that Smith & Wesson Brands will report an earnings per share (EPS) of $0.69.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2022

Upgrades

Benzinga

Greenlane Holdings Says It Can Obtain More Than $30M In Improved Liquidity In 2022

Greenlane Holdings, Inc. (NASDAQ: GNLN) provided an update on its strategy to generate more than $30 million in liquidity, as part of its strategic plan to reduce its cost structure, accelerate its path to profitability, and increase liquidity on a non-dilutive basis.

Benzinga

A Bearish Sign Appears On Principal Finl Gr's Chart

If history is any guide, there may be trouble ahead for shares of Principal Finl Gr (NASDAQ:PFG). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

U.S. Markets Open Lower; Winnebago Posts Upbeat Results

U.S. stocks traded lower this morning, with the Dow Jones dropping around 300 points on Wednesday.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Looking Into NextGen Healthcare's Return On Capital Employed

According to Benzinga Pro data NextGen Healthcare (NASDAQ:NXGN) posted a 93.3% decrease in earnings from Q3. Sales, however, increased by 1.03% over the previous quarter to $151.26 million.

Benzinga

Lulus Fashion Lounge Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, Lulus Fashion Lounge (NASDAQ:LVLU) earned $2.04 million, a 123.28% increase from the preceding quarter. Lulus Fashion Lounge also posted a total of $111.90 million in sales, a 15.64% increase since Q4.

Benzinga

Looking Into Elys Game Technology's Return On Capital Employed

According to data from Benzinga Pro, during Q1, Elys Game Technology's (NASDAQ:ELYS) reported sales totaled $12.24 million. Despite a 68.73% increase in earnings, the company posted a loss of $2.55 million.

Benzinga

Adamis Pharmaceuticals's Return On Capital Employed Overview

Adamis Pharmaceuticals (NASDAQ:ADMP) brought in sales totaling $1.16 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 18.01%, resulting in a loss of $10.35 million.

Benzinga

Scholar Rock Holding Earnings Perspective: Return On Capital Employed

According to Benzinga Pro data, during Q1, Scholar Rock Holding (NASDAQ:SRRK) posted sales of $33.19 million. Earnings were up 77.86%, but Scholar Rock Holding still reported an overall loss of $7.95 million.

Benzinga

OMNIQ's Return On Capital Employed Insights

Benzinga Pro data, OMNIQ (NASDAQ:OMQS) reported Q1 sales of $26.32 million. Earnings fell to a loss of $2.57 million, resulting in a 15.98% decrease from last quarter.

Benzinga

What's Going On With Bed Bath & Beyond Stock Today

Bed Bath & Beyond Inc (NASDAQ: BBBY) shares were initially trading lower Wednesday after several analysts cut price targets on the stock, but have since reversed.

1 … 412 413 414 415

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.